ESS2 p.Pro308Ser
c.922C>T · rs1181202280 · VCV3090614
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6893 | likely pathogenic |
|---|---|---|
| REVEL | 0.673 | pathogenic-leaning |
| SaProt | LLR -9.92 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 10 kb · p 0.16 · regional, not allelic |
| Overall | ||
| CADD | 28.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ESS2
- Protein
- p.Pro308Ser
- Coding
- c.922C>T
- MANE Select
- NM_022719
- dbSNP
- rs1181202280
- Type
- single nucleotide variant
- Location
- chr22:19138218 (GRCh38)
- Gene constraint
- LOEUF 0.844 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 68.41 · 5 PDB
Similar variants
- TSSK2 p.Asp308Asn Uncertain significance ★ ⚠ same residue
- TSSK2 p.Asp308Glu Likely benign ★ same residue
- ESS2 p.Arg175Gln Uncertain significance ★★ ⚠ same type
- ESS2 p.Asn311= Benign ★★ same type
- ESS2 p.Glu234Lys Benign ★★ ⚠ same type
- ESS2 p.His178= Likely benign ★★ same type
- ESS2 p.Lys66= Benign/Likely benign ★★ same type
- ESS2 p.Pro99Leu Benign ★★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ess2-p-pro308ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown